×
S&P 500   3,824.22 (-0.03%)
DOW   30,921.28 (-0.57%)
QQQ   285.59 (+1.23%)
AAPL   140.88 (+1.40%)
MSFT   261.73 (+0.83%)
META   166.88 (+4.28%)
GOOGL   2,255.00 (+3.69%)
AMZN   113.14 (+3.27%)
TSLA   694.33 (+1.84%)
NVDA   148.47 (+2.23%)
NIO   22.02 (+3.09%)
BABA   118.36 (+2.03%)
AMD   74.50 (+1.13%)
MU   56.49 (+5.29%)
CGC   2.67 (-4.98%)
T   21.14 (-0.80%)
GE   61.81 (-2.72%)
F   11.09 (-2.03%)
DIS   96.77 (+0.66%)
AMC   12.61 (-6.80%)
PFE   51.50 (-1.55%)
PYPL   74.21 (+3.94%)
NFLX   184.44 (+2.50%)
S&P 500   3,824.22 (-0.03%)
DOW   30,921.28 (-0.57%)
QQQ   285.59 (+1.23%)
AAPL   140.88 (+1.40%)
MSFT   261.73 (+0.83%)
META   166.88 (+4.28%)
GOOGL   2,255.00 (+3.69%)
AMZN   113.14 (+3.27%)
TSLA   694.33 (+1.84%)
NVDA   148.47 (+2.23%)
NIO   22.02 (+3.09%)
BABA   118.36 (+2.03%)
AMD   74.50 (+1.13%)
MU   56.49 (+5.29%)
CGC   2.67 (-4.98%)
T   21.14 (-0.80%)
GE   61.81 (-2.72%)
F   11.09 (-2.03%)
DIS   96.77 (+0.66%)
AMC   12.61 (-6.80%)
PFE   51.50 (-1.55%)
PYPL   74.21 (+3.94%)
NFLX   184.44 (+2.50%)
S&P 500   3,824.22 (-0.03%)
DOW   30,921.28 (-0.57%)
QQQ   285.59 (+1.23%)
AAPL   140.88 (+1.40%)
MSFT   261.73 (+0.83%)
META   166.88 (+4.28%)
GOOGL   2,255.00 (+3.69%)
AMZN   113.14 (+3.27%)
TSLA   694.33 (+1.84%)
NVDA   148.47 (+2.23%)
NIO   22.02 (+3.09%)
BABA   118.36 (+2.03%)
AMD   74.50 (+1.13%)
MU   56.49 (+5.29%)
CGC   2.67 (-4.98%)
T   21.14 (-0.80%)
GE   61.81 (-2.72%)
F   11.09 (-2.03%)
DIS   96.77 (+0.66%)
AMC   12.61 (-6.80%)
PFE   51.50 (-1.55%)
PYPL   74.21 (+3.94%)
NFLX   184.44 (+2.50%)
S&P 500   3,824.22 (-0.03%)
DOW   30,921.28 (-0.57%)
QQQ   285.59 (+1.23%)
AAPL   140.88 (+1.40%)
MSFT   261.73 (+0.83%)
META   166.88 (+4.28%)
GOOGL   2,255.00 (+3.69%)
AMZN   113.14 (+3.27%)
TSLA   694.33 (+1.84%)
NVDA   148.47 (+2.23%)
NIO   22.02 (+3.09%)
BABA   118.36 (+2.03%)
AMD   74.50 (+1.13%)
MU   56.49 (+5.29%)
CGC   2.67 (-4.98%)
T   21.14 (-0.80%)
GE   61.81 (-2.72%)
F   11.09 (-2.03%)
DIS   96.77 (+0.66%)
AMC   12.61 (-6.80%)
PFE   51.50 (-1.55%)
PYPL   74.21 (+3.94%)
NFLX   184.44 (+2.50%)
NASDAQ:CLNN

Clene Earnings Date, Estimates & Call Transcripts (2022)

$2.58
+0.04 (+1.57%)
(As of 07/5/2022 02:40 PM ET)
Add
Compare
Today's Range
$2.54
$2.67
50-Day Range
$2.10
$4.12
52-Week Range
$1.93
$17.82
Volume
4,843 shs
Average Volume
547,018 shs
Market Capitalization
$163.21 million
P/E Ratio
11.22
Dividend Yield
N/A
Price Target
$12.75

Earnings Summary

Upcoming
Earnings Date
Aug. 9Estimated
Actual EPS
(May. 9)
-$0.21 Missed By -$0.03
Consensus EPS
(May. 9)
-$0.18
Last Year's Q2 EPS
(5/11/2021)
-$0.19
Skip Charts & View Estimated and Actual Earnings Data

CLNN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLNN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Clene Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20221($0.18)($0.18)($0.18)
Q2 20221($0.19)($0.19)($0.19)
Q3 20221($0.15)($0.15)($0.15)
Q4 20221($0.14)($0.14)($0.14)
FY 20224($0.66)($0.66)($0.66)

CLNN Earnings Date and Information

Clene last announced its earnings data on May 9th, 2022. The reported ($0.21) EPS for the quarter, missing analysts' consensus estimates of ($0.18) by $0.03. The company earned $0.03 million during the quarter, compared to the consensus estimate of $0.13 million. Clene has generated $0.23 earnings per share over the last year ($0.23 diluted earnings per share) and currently has a price-to-earnings ratio of 11.2. Earnings for Clene are expected to grow in the coming year, from ($0.73) to ($0.26) per share. Clene has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 9th, 2022 based off prior year's report dates.

Clene Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/9/2022
(Estimated)
        
5/9/2022Q1 2022($0.18)($0.21)($0.03)($0.21)$0.13 million$0.03 million
3/11/2022Q4 2021($0.18)($0.19)($0.01)($0.45)$0.14 million$0.20 million
11/8/2021Q3($0.2020)$0.42+$0.6220($0.48)$0.14 million$0.11 million
8/9/20216/30/2021($0.16)($0.21)($0.05)($0.37)$0.07 million$0.20 million
5/11/2021Q1 2021($0.09)($0.19)($0.10)$0.28$0.07 million$0.21 million
11/3/2020Q3 2020($0.23)($0.23)($0.23)
8/3/2020Q2 2020($0.04)($0.04)($0.04)
5/14/2020Q1 2020($0.08)($0.08)($0.08)
3/24/2020Q4 2019($0.09)($0.09)($0.09)
11/14/2019Q3 2019($0.05)($0.05)($0.05)
8/13/2019Q2 2019($0.03)($0.03)($0.03)
5/3/2019Q1 2019($0.05)($0.05)($0.05)
3/15/2019Q4 2018($0.09)($0.09)($0.09)
11/13/2018Q3 2018($0.05)($0.05)($0.05)
9/6/2018Q2 2018($0.01)($0.01)($0.01)












Clene Earnings - Frequently Asked Questions

When is Clene's earnings date?

Clene has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 9th, 2022 based off last year's report dates. Learn more on CLNN's earnings history.

Did Clene beat their earnings estimates last quarter?

In the previous quarter, Clene (NASDAQ:CLNN) missed the analysts' consensus estimate of ($0.18) by $0.03 with a reported earnings per share (EPS) of ($0.21). Learn more on analysts' earnings estimate vs. CLNN's actual earnings.

How much revenue does Clene generate each year?

Clene (NASDAQ:CLNN) has a recorded annual revenue of $720,000.00.

How much profit does Clene generate each year?

Clene (NASDAQ:CLNN) has a recorded net income of -$9.74 million. CLNN has generated $0.23 earnings per share over the last four quarters.

What is Clene's price-to-earnings ratio?

Clene (NASDAQ:CLNN) has a trailing price-to-earnings ratio of 11.22.

What is Clene's EPS forecast for next year?

Clene's earnings are expected to grow from ($0.73) per share to ($0.26) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:CLNN) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.